Purchase Order HHSN272201700789P

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to the Trustees of Indiana University for clinical-grade adeno-associated virus vector with a firm fixed price of $308,550 on September 27, 2018. Performance occurs in Indianapolis, Indiana, with an ultimate completion date of December 31, 2019. The originating pre-solicitation was posted August 7, 2018, with bids due August 21, 2018.</p>

The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1,968,711 delivery order to Children's Hospital Medical Center, doing business as Children's Home Healthcare, under the master indefinite-delivery/indefinite-quantity contract NIAID Preclinical Models of Infectious Diseases 2017-2024. The delivery order is for NEW TASK ORDER A78 and will be performed in Cincinnati, Ohio over a two-year period from November 4th, 2022 through November 3rd, 2024....

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Life Technologies Corporation valued at $49,500 on August 15, 2017, with completion by September 14, 2017. Performance occurs in Carlsbad, California. The order is firm fixed price with no small business set-aside. The specific requirements and line items are not detailed in the source documentation.</p>

The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $12,810 firm-fixed-price purchase order contract to the University of Florida Division of Sponsored Research to generate specific AAV virus strains (CV5379 and CV5380) for use in ocular infection experiments. This contract was a sole-source award with no set-aside designation, as the University of Florida Ocular Gene Therapy Core has the unique expertise and capability to...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Life Technologies Corporation for biomaterial on August 11, 2015, with a ceiling value of $34,000.00. Performance takes place in Grand Island, New York. The order is firm fixed price with an ultimate completion date of September 30, 2016.</p>

The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $16,345.50 purchase order to Biointron Biological USA Inc. for antibody expression services. As a firm fixed price contract, Biointron will provide the requested antibody expression services to NIH/NIAID at Metuchen, New Jersey from September 19, 2023 through December 29, 2023. No subcontractors or set aside designations were indicated. NIAID conducts and...

The National Institute of Allergy and Infectious Diseases issued a $4.3 million delivery order to American Type Culture Collection on July 1, 2026, under the Pre-Clinical Models of Infectious Diseases IDIQ for screening candidate countermeasures for seasonal and high pathogen avian influenza in a human lung microphysiological system. Place of performance is Manassas, VA. The order runs through June 30, 2027, and is priced on a cost-plus-fixed-fee basis with a ceiling value of $4,298,901. No...

The National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), awarded a $664,000.65 firm fixed price purchase order to Vigene Biosciences, Inc., a minority-owned small business, for the delivery of clinical grade virus vectors. The award was made through a sole source acquisition process under Federal Acquisition Regulation (FAR) Part 12 for commercial items. The vectors are needed to support ongoing research at NIAID's Laboratory...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Life Technologies Corporation for $46,200.00 on June 25, 2019, with completion scheduled for June 27, 2020. The order covers biologicals for delivery to Carlsbad, California. The underlying solicitation was posted June 3, 2019 with a due date of June 17, 2019. Pricing is firm fixed price.</p>

The National Institute of Allergy and Infectious Diseases issued a delivery order to International AIDS Vaccine Initiative Inc. on August 28, 2018, with a ceiling value of $26.065 million for manufacture of human flu challenge material. Work is performed in New York, NY under Cost Plus Fixed Fee pricing, with an ultimate completion date of May 14, 2028. The delivery order supports IAVI's vaccine development and manufacturing services, including process development, analytical testing, cGMP...